Dec 1 (Reuters) - Revive Therapeutics Ltd RVV.V :
* Announces positive final results from its phase 2a study for the treatment of
acute gout flares
* Says Revive actively planning a potentially pivotal phase 2b, double blinded,
placebo controlled trial
* Source text for Eikon ID:nMKWKVbjQa
* Further company coverage RVV.V